These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 12469186)
21. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Itoi T; Watanabe H; Ajioka Y; Oohashi Y; Takel K; Nishikura K; Nakamura Y; Horil A; Saito T Pathol Int; 1996 May; 46(5):333-40. PubMed ID: 8809879 [TBL] [Abstract][Full Text] [Related]
22. [Mutations of APC gene MCR region in sporadic colorectal adenomas and carcinomas]. Wang Y; Liu S; Hao D Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):284-6. PubMed ID: 10920985 [TBL] [Abstract][Full Text] [Related]
23. [Are there differences between ex adenoma and de novo colorectal carcinomas?]. Mueller J; Mueller E; Keller G; Bethke B; Stolte M; Höfler H Verh Dtsch Ges Pathol; 1999; 83():139-47. PubMed ID: 10714204 [TBL] [Abstract][Full Text] [Related]
25. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene. Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549 [TBL] [Abstract][Full Text] [Related]
27. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas. Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma. Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722 [TBL] [Abstract][Full Text] [Related]
29. Histological and genetic changes in malignant transformation of gallbladder adenoma. Watanabe H; Date K; Itoi T; Matsubayashi H; Yokoyama N; Yamano M; Ajioka Y; Nishikura K Ann Oncol; 1999; 10 Suppl 4():136-9. PubMed ID: 10436806 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. Fujii S; Fujimori T; Chiba T J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330 [TBL] [Abstract][Full Text] [Related]
31. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer. Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678 [TBL] [Abstract][Full Text] [Related]
32. Different genetic features associated with colon and rectal carcinogenesis. Frattini M; Balestra D; Suardi S; Oggionni M; Alberici P; Radice P; Costa A; Daidone MG; Leo E; Pilotti S; Bertario L; Pierotti MA Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4015-21. PubMed ID: 15217933 [TBL] [Abstract][Full Text] [Related]
33. High incidence of protein-truncating mutations of the p53 gene in liver metastases of colorectal carcinomas. Miyaki M; Iijima T; Yasuno M; Kita Y; Hishima T; Kuroki T; Mori T Oncogene; 2002 Sep; 21(43):6689-93. PubMed ID: 12242668 [TBL] [Abstract][Full Text] [Related]
34. Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene. Prall F; Weirich V; Ostwald C Histopathology; 2007 Feb; 50(3):318-30. PubMed ID: 17257127 [TBL] [Abstract][Full Text] [Related]
35. Detection of p53 mutations in Hong Kong colorectal carcinomas by conventional PCR-SSCP analysis versus p53 yeast functional assays. Leung CS; Lung ML Anticancer Res; 1999; 19(1A):625-8. PubMed ID: 10226610 [TBL] [Abstract][Full Text] [Related]
36. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas. Hornick JL; Farraye FA; Odze RD Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765 [TBL] [Abstract][Full Text] [Related]
38. Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumors. Minarik M; Minarikova L; Hrabikova M; Minarikova P; Hrabal P; Zavoral M Electrophoresis; 2004 Apr; 25(7-8):1016-21. PubMed ID: 15095442 [TBL] [Abstract][Full Text] [Related]
39. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360 [TBL] [Abstract][Full Text] [Related]
40. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]